Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis

from The Studio at Kendall Square · host BiotechTV

Dr. Excoffon describes her academic experience that led her to the field and Spirovant Sciences, discusses interesting data from last month’s North American Cystic Fibrosis Conference, and then highlights Spirovant’s program and why using a small molecule modulator like doxorubicin might be the key to success.

Episode metadata supplied by the publisher feed · Published Oct 3, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis

0:00 24:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Studio at Kendall Square?

This episode is 24 minutes long.

When was this The Studio at Kendall Square episode published?

This episode was published on October 3, 2024.

Can I download this The Studio at Kendall Square episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!